Table 3.
Characteristics of SMA and their use in practices
| Practice | SMA condition(s) | No. SMAs delivered | SMA status at interview | Staff delivering SMA | Practice list size (patients) | Setting (deprivation levelb) | |
|---|---|---|---|---|---|---|---|
| Clinician | Facilitator | ||||||
| A | risk of familial hypercholesterolemia | 7 | not running | GP | manager/ administrator | 7,000 | rural (HD) |
| B | diabetes, asthma, high cholesterol | > 25 | using regularly | Nurse/external clinician | manager/ administrator | 10,000 | major urban (LD) |
| C | diabetes | 1 | not running | nurse | administrator | 13,000 | major urban (HD) |
| D | multi-morbidities | 6 | using regularly | nurse | healthcare assistant | 16,000 | major urban (HD) |
| E | high cholesterol, asthma, COPD | > 25 | using regularly | pharmacist/ GP/nurses | unclear | 20,000 | major urban (HD) |
| F | diabetes | 1 | just started | nurse | healthcare assistant | 36,000 | city & town (HD) |
| Ga | chronic pain | > 25 | yes – trialling video SMAs) | GP/ pharmacist/ nurse | unclear | 12,000 | major urban (HD) |
| Ha | multimorbidity to include: overweight / obesity / hypertension, pre-diabetes / type 2 diabetes | 6 | not running | GP | healthcare assistant | 12,000 | city & town (HD) |
GP general practitioner
aInterviewed during height of pandemic
bHD Higher deprivation (Indices of multiple deprivation deciles 1–5), LD Lower deprivation (Indices of multiple deprivation deciles 6–10)